Press Releases about Lexaria Bioscience Corp
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Via ACCESSWIRE
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Begins Dosing in Its Human Oral Nicotine Study
December 20, 2022
Via CannabisNewsWire
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Lexaria’s Human Oral Nicotine Study Begins Dosing
December 20, 2022
Via ACCESSWIRE
Lexaria Bioscience Corp.’s (NASDAQ: LEXX) 2022 Calendar Year in Review
December 13, 2022
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.